These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 17699335)
1. Studying the prevention of acute kidney injury: lessons from an 18th-century mathematician. Chertow GM; Palevsky PM; Greene T Clin J Am Soc Nephrol; 2006 Sep; 1(5):1124-7. PubMed ID: 17699335 [No Abstract] [Full Text] [Related]
2. Statistics and the relationship of clinical research to clinical practice. Khuder SA; Kahaleh B J Rheumatol; 2009 Feb; 36(2):219-20. PubMed ID: 19208555 [No Abstract] [Full Text] [Related]
3. Sample size and the probability of a successful trial. Chuang-Stein C Pharm Stat; 2006; 5(4):305-9. PubMed ID: 17128428 [TBL] [Abstract][Full Text] [Related]
4. When less is more: using shrinkage to increase accuracy. Wears RL; Normand SL Ann Emerg Med; 2010 Jun; 55(6):553-5. PubMed ID: 20494223 [No Abstract] [Full Text] [Related]
6. Further discussion on the design and analysis of thorough QTc clinical trials: guest editors' notes. Tsong Y; Zhang J J Biopharm Stat; 2010 May; 20(3):493-6. PubMed ID: 20358431 [No Abstract] [Full Text] [Related]
7. What is the logic in mixing data and beliefs? Brown PM Pharm Stat; 2007; 6(1):5-8. PubMed ID: 17256805 [No Abstract] [Full Text] [Related]
8. Evaluation of the statistical power for multiple tests: a case study. Yeo A; Qu Y Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588 [TBL] [Abstract][Full Text] [Related]
9. Adaptive design in clinical research: issues, opportunities, and recommendations. Chang M; Chow SC; Pong A J Biopharm Stat; 2006 May; 16(3):299-309; discussion 311-2. PubMed ID: 16724486 [TBL] [Abstract][Full Text] [Related]
10. Adaptive methods: when and how should they be used in clinical trials? Porcher R; Lecocq B; Vray M; Therapie; 2011; 66(4):319-26, 309-17. PubMed ID: 21851793 [TBL] [Abstract][Full Text] [Related]
11. Optimal Bayesian design for patient selection in a clinical study. Buzoianu M; Kadane JB Biometrics; 2009 Sep; 65(3):953-61. PubMed ID: 19021600 [TBL] [Abstract][Full Text] [Related]
12. Practical usage of O'Brien's OLS and GLS statistics in clinical trials. Dallow NS; Leonov SL; Roger JH Pharm Stat; 2008; 7(1):53-68. PubMed ID: 17390306 [TBL] [Abstract][Full Text] [Related]
14. Statistical considerations on design and analysis of bridging and multiregional clinical trials. Tsong Y J Biopharm Stat; 2012 Sep; 22(5):1078-80. PubMed ID: 22946952 [No Abstract] [Full Text] [Related]
15. Note on special technical issue on adaptive designs for clinical trials. Liu Q; Chang M J Biopharm Stat; 2012; 22(4):615-6. PubMed ID: 22651104 [No Abstract] [Full Text] [Related]
16. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials. Daimon T Contemp Clin Trials; 2008 Jul; 29(4):507-16. PubMed ID: 18201944 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the Gould-Shih procedure for sample size re-estimation. Waksman JA Pharm Stat; 2007; 6(1):53-65. PubMed ID: 17133631 [TBL] [Abstract][Full Text] [Related]
18. How to design a clinical trial. Curtis BM; Barrett BJ; Parfrey PS Methods Mol Med; 2003; 86():475-89. PubMed ID: 12886789 [No Abstract] [Full Text] [Related]
19. Sample size calculation for the van Elteren test adjusting for ties. Zhao YD; Rahardja D; Mei Y J Biopharm Stat; 2008; 18(6):1112-9. PubMed ID: 18991111 [TBL] [Abstract][Full Text] [Related]
20. 31st Annual Conference of the International Society for Clinical Biostatistics. Preface. Lesaffre E; Gerds T Stat Med; 2012 May; 31(11-12):1001. PubMed ID: 22585410 [No Abstract] [Full Text] [Related] [Next] [New Search]